Literature DB >> 7945312

A novel cationic amphiphile for transfection of mammalian cells.

J M Ruysschaert1, A el Ouahabi, V Willeaume, G Huez, R Fuks, M Vandenbranden, P Di Stefano.   

Abstract

We describe here a new cationic amphiphile, N-t-butyl-N'-tetradecyl-3-tetradecylaminopropionamidine (diC14-amidine), which interacts with plasmid DNA and generates hydrophobic stable complexes resistant against DNase I. In partition experiments between two non-miscible phases, DNA was transferred into an organic phase upon complex formation with diC14-amidine-containing vesicles. Finally, vesicles made of a diC14-amidine and phosphatidylethanolamine (PE) (1:1, mol:mol) mixture or pure diC14-amidine were efficient in mediating transfection of adherent (CHO) and suspension (K562) cell lines, using the chloramphenicol acetyltransferase (CAT) gene as reporter.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945312     DOI: 10.1006/bbrc.1994.2372

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

Review 1.  Design considerations for liposomal vaccines: influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens.

Authors:  Douglas S Watson; Aaron N Endsley; Leaf Huang
Journal:  Vaccine       Date:  2012-02-02       Impact factor: 3.641

2.  In vivo gene delivery to the liver using reconstituted chylomicron remnants as a novel nonviral vector.

Authors:  T Hara; Y Tan; L Huang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 3.  Transfection by cationic gemini lipids and surfactants.

Authors:  M Damen; A J J Groenen; S F M van Dongen; R J M Nolte; B J Scholte; M C Feiters
Journal:  Medchemcomm       Date:  2018-07-17       Impact factor: 3.597

Review 4.  Structural insights on biologically relevant cationic membranes by ESR spectroscopy.

Authors:  Julio H K Rozenfeld; Evandro L Duarte; Tiago R Oliveira; M Teresa Lamy
Journal:  Biophys Rev       Date:  2017-08-23

5.  Targeted gene transfection from microbubbles into vascular smooth muscle cells using focused, ultrasound-mediated delivery.

Authors:  Linsey C Phillips; Alexander L Klibanov; Brian R Wamhoff; John A Hossack
Journal:  Ultrasound Med Biol       Date:  2010-09       Impact factor: 2.998

6.  Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression.

Authors:  Benjamin Le Calvé; Michal Rynkowski; Marie Le Mercier; Céline Bruyère; Caroline Lonez; Thierry Gras; Benjamin Haibe-Kains; Gianluca Bontempi; Christine Decaestecker; Jean-Marie Ruysschaert; Robert Kiss; Florence Lefranc
Journal:  Neoplasia       Date:  2010-09       Impact factor: 5.715

7.  Biophysical and transfection studies of the diC(14)-amidine/DNA complex.

Authors:  Vadim Cherezov; Hong Qiu; Veronique Pector; Michel Vandenbranden; Jean-Marie Ruysschaert; Martin Caffrey
Journal:  Biophys J       Date:  2002-06       Impact factor: 4.033

8.  Fusogenic activity of cationic lipids and lipid shape distribution.

Authors:  Caroline Lonez; Marc F Lensink; Emilie Kleiren; Jean-Marie Vanderwinden; Jean-Marie Ruysschaert; Michel Vandenbranden
Journal:  Cell Mol Life Sci       Date:  2009-11-19       Impact factor: 9.261

9.  Critical residues involved in Toll-like receptor 4 activation by cationic lipid nanocarriers are not located at the lipopolysaccharide-binding interface.

Authors:  Caroline Lonez; Kate L Irvine; Malvina Pizzuto; Boris I Schmidt; Nick J Gay; Jean-Marie Ruysschaert; Monique Gangloff; Clare E Bryant
Journal:  Cell Mol Life Sci       Date:  2015-05-09       Impact factor: 9.261

10.  Toll-like receptor 2 promiscuity is responsible for the immunostimulatory activity of nucleic acid nanocarriers.

Authors:  Malvina Pizzuto; Monique Gangloff; Daniel Scherman; Nicholas J Gay; Virginie Escriou; Jean-Marie Ruysschaert; Caroline Lonez
Journal:  J Control Release       Date:  2016-12-28       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.